ASMVF yields 0.35% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, ASMVF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASMVF + JNJ for your $10,000?
ASMPT Limited, an investment holding company, engages in the design, manufacture, and marketing of machines, tools, and materials used in the semiconductor and electronics assembly industries worldwide. It operates through Semiconductor Solutions and Surface Mount Technology Solutions segments. The company provides deposition process equipment, wafer separation equipment, AOI/FOL equipment, die attach equipment, wire bonding equipment, dispensing equipment, encapsulation solutions equipment, and CIS equipment. It also offers singulation, trim, and form systems; LED testing, sorting, and taping systems; sintering equipment; and test and finish handling systems. In addition, the company offers surface mount technologies; advanced packaging solutions; encapsulation solutions; MEM solutions; power solutions; LED/opto solutions; photonics solutions; COB solutions; stacked die solutions; and smart SMT factory solutions, as well as image sensor applications. Further, it provides agency and logistics services. The company was formerly known as ASM Pacific Technology Limited and changed its name to ASMPT Limited in June 2022. ASMPT Limited was founded in 1975 and is based in Tsing Yi, Hong Kong.
Full ASMVF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.